Helsinki, Finland
Switchpoint Bio
$5.3M
Pre-Seed
Summary
Switchpoint Bio raised $5.3 million in pre-seed financing, including a $5 million investment from Treehouse Delmar Investments. Switchpoint Bio is a developer of blood-based epigenomic profiling for drug development.